Myrrh for Anti-Inflammatory

Research suggests that myrrh possesses notable anti-inflammatory properties, with studies indicating it can suppress key inflammatory mediators such as TNF-α, nitric oxide, prostaglandin E2, and various cytokines through multiple signaling pathways including JNK and PI3K inhibition. The available evidence comes primarily from laboratory cell studies and animal models — including rat models of ulcerative colitis, glomerulonephritis, and sepsis, as well as mouse immune cell assays — with several review articles synthesizing myrrh's broader pharmacological profile and attributing its activity to terpenoid and diterpenoid compounds; notably, there are few rigorous human clinical trials directly testing myrrh's anti-inflammatory effects in isolation. Some studies also indicate that myrrh may work synergistically when combined with other botanicals such as frankincense, chamomile, and coffee charcoal, potentially producing stronger anti-inflammatory effects than myrrh alone, and one animal study found its effects on colitis comparable to the pharmaceutical drug mesalazine at higher doses. While the overall direction of the research is consistently supportive, the predominance of preclinical evidence means that conclusions about effectiveness in humans remain preliminary, and further well-designed clinical trials are needed to confirm these findings.